Henrietta Fore - Director, Theravance Biopharma, Inc
As of August 11, 2017
What is Henrietta Fore's Net Worth?
The current estimated net worth of Theravance Biopharma, Inc's Director, Henrietta Fore, is estimated to be about $5.84M . Henrietta Fore owns about 24,000 units of Theravance Biopharma, Inc common stock. In the last 3 years at Theravance Biopharma, Inc, Henrietta Fore has sold an estimated value of $0 worth.
What is Henrietta Fore's Past Insider Trading?
Henrietta Fore's largest purchase order was 6,000 units , worth over $143.93K on August 11, 2017. In total, Henrietta Fore has made about 5 transactions over 3 years of their time at Theravance Biopharma, Inc. Henrietta Fore usually trades in May, with the busiest year in 2017.
Henrietta Fore
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Henrietta Fore's' Mailing Address?
- Mailing address is Theravance, Inc. 901 Gateway Blvd. South San Francisco CA 94080 CA
Theravance Biopharma, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Rick E Winningham | 2020 | $1,014,455 | - | $579,646 | - | $579,646 | $6,045 | $6,577,746 |
| Rick E Winningham | 2019 | $983,710 | - | $473,906 | - | $473,906 | $5,496 | $5,932,411 |
| Rick E Winningham | 2018 | $956,600 | $74,767 | $690,154 | - | $690,154 | $5,000 | $2,522,841 |
| Andrew A. Hindman | 2020 | $551,608 | - | $265,278 | - | $265,278 | $5,920 | $2,097,950 |
| Andrew A. Hindman | 2019 | $315,000 | $175,000 | $216,000 | $2,204,956 | $216,000 | - | $3,757,956 |
| Brett Haumann | 2020 | $572,569 | - | $213,589 | - | $213,589 | $53,267 | $2,742,625 |
| Brett Haumann | 2019 | $543,047 | - | $170,000 | - | $170,000 | $42,382 | $2,464,280 |
| Brett Haumann | 2018 | $497,810 | $34,125 | $315,000 | - | $315,000 | $414,300 | $1,517,194 |
| Vijay Sabesan | 2020 | $407,677 | - | $760,326 | - | $760,326 | $6,541 | $3,077,744 |
| Bradford J. Shafer | 2020 | $556,321 | - | $264,999 | - | $264,999 | $6,045 | $2,730,565 |
| Bradford J. Shafer | 2019 | $537,403 | - | $215,611 | - | $215,611 | $6,983 | $2,468,848 |
| Bradford J. Shafer | 2018 | $518,080 | $33,770 | $311,726 | - | $311,726 | $5,000 | $1,124,537 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1583107/000110465921039784/tm212357-1_def14a.htm
What are Theravance Biopharma, Inc's Past Insider Trades?
Theravance Biopharma, Inc's most recent insider trade came on May 24, 2022 by Rhonda Farnum who sold 3,281 units worth $28.88K . In the last 7 years, insiders at Theravance Biopharma, Inc have sold an estimated value of $52.4M and bought an estimated value of $26.3M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Bradford Shafer, EVP, Rick Winningham, CHIEF EXECUTIVE OFFICER, and Philip Worboys, SVP .
Theravance Biopharma, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||